These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Does admission NT-proBNP increase the prognostic accuracy of GRACE risk score in the prediction of short-term mortality after acute coronary syndromes? Timóteo AT; Toste A; Ramos R; Miranda F; Ferreira ML; Oliveira JA; Ferreira RC Acute Card Care; 2009; 11(4):236-42. PubMed ID: 19742352 [TBL] [Abstract][Full Text] [Related]
4. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population. Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868 [TBL] [Abstract][Full Text] [Related]
5. [The significance of serum N-terminal pro-brain natriuretic peptide levels for prognosis of patients in intensive care unit]. Liu J; Zhang X; Liu Y; Wang B; Wang Y Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jul; 26(7):489-92. PubMed ID: 25027427 [TBL] [Abstract][Full Text] [Related]
6. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors. Suzuki S; Sugiyama S Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934 [TBL] [Abstract][Full Text] [Related]
7. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134 [TBL] [Abstract][Full Text] [Related]
8. N-terminal pro brain natriuretic peptide in the management of patients in the medical emergency department (PROMPT): correlation with disease severity, utilization of hospital resources, and prognosis in a large, prospective, randomized multicentre trial. Luchner A; Möckel M; Spanuth E; Möcks J; Peetz D; Baum H; Spes C; Wrede CE; Vollert J; Müller R; Katus H; Giannitsis E Eur J Heart Fail; 2012 Mar; 14(3):259-67. PubMed ID: 22265921 [TBL] [Abstract][Full Text] [Related]
9. Early discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk Score. Schellings DA; Adiyaman A; Giannitsis E; Hamm C; Suryapranata H; Ten Berg JM; Hoorntje JC; Van't Hof AW J Am Heart Assoc; 2014 Nov; 3(6):e001089. PubMed ID: 25389283 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of N-Terminal Pro-B-Type Natriuretic Peptide in Takotsubo syndrome. Stiermaier T; Santoro F; Graf T; Guastafierro F; Tarantino N; De Gennaro L; Caldarola P; Di Biase M; Thiele H; Brunetti ND; Möller C; Eitel I Clin Res Cardiol; 2018 Jul; 107(7):597-606. PubMed ID: 29675571 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with active infective endocarditis. Kahveci G; Bayrak F; Mutlu B; Bitigen A; Karaahmet T; Sonmez K; Izgi A; Degertekin M; Basaran Y Am J Cardiol; 2007 May; 99(10):1429-33. PubMed ID: 17493474 [TBL] [Abstract][Full Text] [Related]
12. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study. Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696 [TBL] [Abstract][Full Text] [Related]
13. The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study. He WF; Jiang L; Chen YY; Liu YH; Chen PY; Duan CY; Zeng LH; Fan HL; Wei XB; Guo W; Chen W; Li J; Li WS; Guo ZQ; Liu ZK; Tan N; Chen JY; He PC BMC Cardiovasc Disord; 2021 Apr; 21(1):202. PubMed ID: 33882836 [TBL] [Abstract][Full Text] [Related]
14. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients. Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544 [TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-B-type natriuretic peptide and outcomes in type B aortic dissection in China: a retrospective multicentre study. Luo C; Zhou J; Xiong S; Kang Z; Zhang J; Sun Y; Qin B; Fang K BMJ Open; 2019 Sep; 9(9):e029885. PubMed ID: 31492783 [TBL] [Abstract][Full Text] [Related]
16. The Prognostic Value of Serum Levels of Heart-Type Fatty Acid Binding Protein and High Sensitivity C-Reactive Protein in Patients With Increased Levels of Amino-Terminal Pro-B Type Natriuretic Peptide. Jeong JH; Seo YH; Ahn JY; Kim KH; Seo JY; Kim MJ; Lee HT; Park PW Ann Lab Med; 2016 Sep; 36(5):420-6. PubMed ID: 27374706 [TBL] [Abstract][Full Text] [Related]
17. Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure. Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Verdiani V; Tijssen JG; Pinto YM JACC Heart Fail; 2015 Oct; 3(10):751-61. PubMed ID: 26449995 [TBL] [Abstract][Full Text] [Related]
18. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400 [TBL] [Abstract][Full Text] [Related]
19. Procalcitonin and N-Terminal Pro-B-Type Natriuretic Peptide for Prognosis in Septic Acute Kidney Injury Patients Receiving Renal Replacement Therapy. Sheng X; Yang J; Yu G; Fei Y; Bao H; Yin J; Huang W; Tian Z; Wang N; Ronco C Blood Purif; 2019; 48(3):262-271. PubMed ID: 31311006 [TBL] [Abstract][Full Text] [Related]
20. Copeptin and NT-proBNP for prediction of all-cause and cardiovascular death in ischemic stroke. Tu WJ; Ma GZ; Ni Y; Hu XS; Luo DZ; Zeng XW; Liu Q; Xu T; Yu L; Wu B Neurology; 2017 May; 88(20):1899-1905. PubMed ID: 28424274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]